Form D · Biotechnology
Phoenix Cardiac Devices, Inc.
Cary, NC · CIK 0001751600
Offering snapshot reported May 7, 2019 · SEC filing
- Reported sold
- $4.97M Offering amount: $5.5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Apr 23, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 7, 2019 | Initial | $4,967,600 | No comparison | 7 | SEC filing |
| Sep 18, 2018 | Amendment | $2,207,500 | $109,500vs Aug 31, 2018 | 6 | SEC filing |
| Aug 31, 2018 | Initial | $2,098,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-338944
Source: Form D, filed May 7, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sreekanth Beeram | Director |
| Kavya Gopal | Director |
| Gopal Muppirala | Director, Executive |
| Jaishankar Raman | Director |
| Vikas Saluguti | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5000 Centergreen Way Suite 500
Cary, NC, 27513
Cary, NC, 27513